Stay updated on PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer
Sign up to get notified when there's something new on the PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer page.

Latest updates to the PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page's revision label was updated from v3.6.2 to v3.6.3, indicating a new published version of the page.SummaryDifference0.1%

- Check26 days agoChange DetectedThe study page shows a new revision label (v3.6.2), indicating a recent update to the record that supersedes the previous version (v3.6.0).SummaryDifference0.1%

- Check40 days agoChange DetectedRecruitment status was updated to indicate no participant enrollment; new help and navigation sections were added, and the Intervention/Treatment heading was standardized, with the revision tag updated to v3.6.0.SummaryDifference0.5%

- Check48 days agoChange DetectedRevision version updated from v3.5.4 to v3.5.5, indicating a new page version. This is a metadata update that does not alter visible content or functionality.SummaryDifference0.1%

- Check69 days agoChange DetectedRevision label on the study page changed from v3.5.3 to v3.5.4, signaling a minor update to the ClinicalTrials.gov record. No substantive study content, such as eligibility criteria or results, appears to be affected by this change.SummaryDifference0.1%

- Check90 days agoChange DetectedThe page revision/version indicator was updated from “v3.5.2” to “v3.5.3,” reflecting a minor site release without changing the displayed study details.SummaryDifference0.1%

Stay in the know with updates to PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer
Enter your email address, and we'll notify you when there's something new on the PANDORE Clinical Trial: Pembrolizumab in Bladder Cancer page.